|
EBMT
CLWP and LWP survey on the outcome of autologous and allogeneic stem cell transplantation
for Richters transformation The
CLL subcommittee of the Chronic Leukemia Working Party is conducting a survey
to identify patients with Richter's transformation. Currently these patients are
not clearly registered in the EBMT database. We hope that your participation in
collecting data for this small but very interesting patient's group will help
to provide further data concerning a retrospective survey regarding patients transplanted
from 1997 to 2006. To
download a pdf version of the survey, click here  Data
will be collected through a pre filled MedB form, click here  Additional
Information can be found in the study invitation letter, click here  The
survey should be completed and sent to the address below or to the following fax
numbers +49 180 500 290 623/+49 711 4900 8723 before 30th November, 2007 Data
Office Chronic Leukaemia
Working Party Department of Medical Statistics & Bioinformatica Postzone
S-05-P LUMC, PO Box 9600 2300 RC Leiden, The Netherlands e-mail: clwpebmt@LUMC.NL

Transplants
with non myeloablative conditioning regimens for myeloid metaplasia with myelofibrosis
(MMM) The
number of reports on the use of non myeloablative conditioning regimens in different
diseases is rapidly increasing. There have been few reports on the use of non
myeloablative conditioning regimens for myeloid metaplasia with myelofibrosis
(MMM). Since this seems to be a very interesting indication, the MDS Subcommittee
of the Chronic Leukemia Working Party of the EBMT is interested in collecting
data on non myeloablative transplants in this rare disease. A short
questionnaire on non myeloablative conditioning regimens for myeloid metaplasia
with myelofibrosis (Primary MMM, post-Polycythemia Vera or post-Essential Thrombocythemia)
can be downloaded below: Questionnaire
Please
return the completed questionnaire by fax: 49-511-532-9662 or mail: hertenstein.bernd@mh-hannover.de
Please do also respond if you did not perform non myeloablative transplants
in these patients. We highly appreciate your participation.
|